NewTradingView.com – Investing and Stock News
Investing and Stock News
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Editor's Pick

Teenage cancer patient’s final fight becomes law as House passes landmark pediatric bill

by December 6, 2025
written by December 6, 2025

A teenage girl who spent her final years advocating for young people battling cancer is forever memorialized in history, thanks to a key bill passed by the House of Representatives.

Mikaela Naylon was just 16 when she died five years after being diagnosed with osteosarcoma, a rare form of bone cancer.

Rep. Michael McCaul, R-Texas, who helped lead the landmark legislation that became her namesake, said Mikaela spent much of that time fighting to give fellow children a chance to survive cancer.

He told Fox News Digital that he viewed childhood cancer patients as ‘the best advocates’ for their cause, calling them his ‘better angels.’

‘Mikaela was a great example of that,’ McCaul said. ‘She was very sick. She’d just undergone radiation and chemotherapy. She wasn’t feeling very well, and I could tell. But she still made the effort to come to Washington, to go to members’ offices and advocate for the legislation.’

The Mikaela Naylon Give Kids A Chance Act is aimed at expanding children’s access to existing cancer therapy trials, as well as incentivizing development of treatments and solutions for pediatric cancer.

It reauthorizes funding for the National Institutes of Health (NIH) to support pediatric disease research through fiscal year 2027, and extends the Food and Drug Administration’s (FDA) ability to expedite review of drugs aimed at helping certain pediatric illnesses.

‘It’s probably one of the most rewarding things I’ve done is to not only draw awareness to childhood cancer by forming the [Childhood Cancer Caucus] and then having an annual summit, but to be able to pass legislation that results in saving children’s lives. I don’t think there’s anything more important than that,’ McCaul said.

His bill passed the House unanimously on Monday, with both Republicans and Democrats speaking out in strong support for the legislation.

Mikaela’s family was in attendance to watch both its passage and the speeches lawmakers gave in favor of it.

‘Nothing will take the place of her. But it helped fill kind of a void, an emptiness they have right now. And they’re very proud of that, that her legacy is carried on through this legislation,’ McCaul, who also gave the Naylon family a tour of the U.S. Capitol, said.

Mikaela’s parents Kassandra and Doug, and her brother Ayden, told Fox News Digital that she had ‘faced every day with hope, purpose and a fierce determination to make the world better for the kids who would come after her.’

‘She believed that all children, no matter how rare their diagnosis, deserve access to the most promising treatments and a real chance at life. This legislation reflects that mission,’ the Naylon family told Fox News Digital.

They thanked McCaul as well as Reps. Debbie Dingell, D-Mich., and Gus Bilirakis, R-Fla., for championing the bill, as well as advocacy groups who also helped shepherd it forward.

‘Their commitment ensures that Mikaela‘s voice, and the voices of so many brave children like her, will forever be heard in the halls of Congress,’ the family said.

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
State-level AI rules survive — for now — as Senate sinks moratorium despite White House pressure
next post
DAVID MARCUS: Trump’s aggression toward Venezuela a warning to Putin

You may also like

Congress blocks Obamacare subsidies after shutdown fight, premiums...

December 31, 2025

Ukraine–Russia at a crossroads: How the war evolved...

December 31, 2025

Two African nations ban American citizens in diplomatic...

December 31, 2025

ISIS exploiting Syria’s chaos as US strikes expose...

December 31, 2025

Congress fails to save Obamacare subsidies after shutdown...

December 31, 2025

DAN GAINOR: These are the seven most annoying...

December 31, 2025

Putin residence drone attack dismissed as ‘implausible’ as...

December 31, 2025

DOJ’s second-in-command could be central to ‘vindictive’ prosecution...

December 30, 2025

Tatiana Schlossberg, JFK’s granddaughter, dies at 35 after...

December 30, 2025

Senate races to avoid government shutdown with time...

December 30, 2025
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!




    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Popular Posts

    • 1

      Gold and Silver: Gold remains stable in the $2420 zone

    • 2

      Oil and natural gas: Oil is back on the positive side

    • 3

      The dollar index continues to pull back to a new low

    • 4

      IonQ Stock Review: Should You Consider Investing Now?

    • 5

      Gold Price Surge Hits $3,385 Amid Trade Tensions

    Recent Posts

    • Ukraine–Russia at a crossroads: How the war evolved in 2025 and what comes next

      December 31, 2025
    • Congress blocks Obamacare subsidies after shutdown fight, premiums set to surge

      December 31, 2025
    • Evening digest: tech rally cools, Kraken spins out, Bitcoin flashes warning signs

      December 31, 2025
    • Michael Burry strikes again: Molina Healthcare in focus this time

      December 31, 2025
    • ASTS stock surges 6.5%: will BlueBird 6 turn satellite-to-phone dreams into reality?

      December 31, 2025

    Categories

    • Economy (20)
    • Editor's Pick (334)
    • Investing (156)
    • Stock (20)
    • About us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: NewTradingView.com, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2025 NewTradingView.com All Rights Reserved.


    Back To Top
    NewTradingView.com – Investing and Stock News
    • Investing
    • Stock
    • Economy
    • Editor’s Pick